Log in to save to my catalogue

Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer...

Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6101492

Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer patients with pathological complete response after pre-operative chemoradiotherapy

About this item

Full title

Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer patients with pathological complete response after pre-operative chemoradiotherapy

Publisher

England: Oxford University Press

Journal title

Gastroenterology report, 2018-08, Vol.6 (3), p.195-201

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

Subjects

More information

Scope and Contents

Contents

The necessity for adjuvant chemotherapy (ACT) in locally advanced rectal cancer (LARC) patients who achieve pathological complete response (pCR) after pre-operative chemoradiotherapy (CRT) is still not identified. We aimed to investigate the therapeutic value of ACT in these patients.
Clinical data were retrospectively collected from 105 consecu...

Alternative Titles

Full title

Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer patients with pathological complete response after pre-operative chemoradiotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6101492

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6101492

Other Identifiers

ISSN

2052-0034

E-ISSN

2052-0034

DOI

10.1093/gastro/goy009

How to access this item